Solatorio, Juan B.
HRN: 24-57-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/09/2024
CEFTAZIDIME 1GM (VIAL)
02/09/2024
02/15/2024
IV
1g
Q8
CAP-ME; T/C MDR-PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes